New approach for Lung cancer management shares by prof. Mohammed Sabry Alkady NorthStar Trial — ESMO 2025
New approach for Lung cancer management shares by prof. Mohammed Sabry Alkady NorthStar Trial — ESMO 2025 Local Consolidative Therapy + Osimertinib Improves PFS in EGFR-Mutant NSCLC Design Phase III study including EGFR ex19del / L858R / T790M patients with non-progressive disease after Osimertinib induction. Participants were randomized to: • Osimertinib + LCT (surgery / […]






